Rhinomed Ltd (RNO)

Sydney
0.315
0.000(0.00%)
  • Volume:
    23,447
  • Bid/Ask:
    0.310/0.315
  • Day's Range:
    0.315 - 0.320

RNO Overview

Prev. Close
0.315
Day's Range
0.315-0.32
Revenue
3.9M
Open
0.32
52 wk Range
0.1-0.485
EPS
-0.03
Volume
23,447
Market Cap
79.95M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
935,343
P/E Ratio
-
Beta
1.09
1-Year Change
80%
Shares Outstanding
253,809,132
Next Earnings Date
30 Nov 2021
What is your sentiment on Rhinomed Ltd?
or
Market is currently closed. Voting is open during market hours.

Rhinomed Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellBuyBuy
Technical IndicatorsBuyStrong SellNeutralSellStrong Buy
SummaryNeutralStrong SellNeutralNeutralStrong Buy

Rhinomed Ltd Company Profile

Rhinomed Ltd Company Profile

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company’s product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.